ABSTRACT
Approximately 21% of patients with bipolar disorder (BD) also have an additional diagnosis of obsessive-compulsive disorder (OCD). This condition is associated with a more severe prognosis and complicates the treatment of BD. In our case report we provide documentary evidence of our experience with trazodone prolonged release in the treatment of depressive phase in a patient with BD II-OCD comorbidity. Rationality in the choise of treatment was based on the need to manage depressive and obsessive symptoms without facilitating hypomania switches.
Subject(s)
Anti-Anxiety Agents/therapeutic use , Bipolar Disorder/drug therapy , Obsessive-Compulsive Disorder/drug therapy , Trazodone/therapeutic use , Adult , Bipolar Disorder/complications , Bipolar Disorder/diagnosis , Comorbidity , Humans , Obsessive-Compulsive Disorder/complications , Obsessive-Compulsive Disorder/diagnosis , Treatment OutcomeABSTRACT
Schizophrenia could be considered the most severe of all psychiatric disorders. It shows a heterogeneous clinical picture and presents an etiopathogenesis that is not cleared sufficiently. Even if the etiopathogenesis remains a puzzle, there is a scientific consensus that it is an expression of interaction between genotype and environmental factors. In the present article, following a study of literature and the accumulated evidence, the role of prenatal and perinatal factors in the development of schizophrenia will be revised and synthesized. We think that better knowledge of the risk factors could be helpful not only for better comprehension of the pathogenesis but especially to optimize interventions for prevention of the disorder.
